Antiretroviral therapy CNS penetration and HIV-1–associated CNS disease

OBJECTIVE: The impact of different antiretroviral agents on the risk of developing or surviving CNS disease remains unknown. The aim of this study was to investigate whether using antiretroviral regimens with higher CNS penetration effectiveness (CPE) scores was associated with reduced incidence of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Garvey, L., Winston, A., Walsh, J., Post, F., Porter, K., Gazzard, B., Fisher, M., Leen, C., Pillay, D., Hill, T., Johnson, M., Gilson, R., Anderson, J., Easterbrook, P., Bansi, L., Orkin, C., Ainsworth, J., Palfreeman, A., Gompels, M., Phillips, A.N., Sabin, C.A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2011
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3053326/
https://ncbi.nlm.nih.gov/pubmed/21339496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e31820d8b0b
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak